Resident Research Grant

VCS RESIDENT RESEARCH GRANT INFORMATION

OVERVIEW: In 2016, the Veterinary Cancer Society (VCS) announced the creation of research support for residents participating in AVMA-approved training programs offering up to $20,000 to perform hypothesis driven, prospective studies that will require approximately one year to complete.  Three grants were funded in 2017.


NOVAVIVE, Inc. PARTNERSHIP WITH VCS IN 2018

In addition to the two grants provided by VCS in 2018, NovaVive, Inc. has donated an additional $20,000 to VCS which will be used to support a resident grant.  In addition to the funds, NovaVive, Inc. will provide up to 200 Immunocidin Canine (2.5mL) vials for completion of a clinical (in vivo) research project.  Preference will be given to, but not limited to, projects involving canine malignant melanoma, soft tissue sarcoma, squamous cell carcinoma and osteosarcoma.  This project must also begin June 1, 2018 and all submissions must occur within the time frame noted within the key date details listed on this page.


ELIGIBILITY:

  • Any resident participating in an AVMA-approved training program is eligible to apply.
  • Either clinical or basic research projects in the field of veterinary or comparative oncology are eligible for consideration.
  • Resident must be a current member of the Veterinary Cancer Society and remain so for the duration of the trial.

CRITERIA FOR AWARD SELECTION:

  • Proposals will be reviewed by a committee comprised of VCS members with expertise in clinical and basic veterinary oncology research.
  • Specific criteria used in consideration of proposals will include:
    • Potential of the study to enhance existing scientific knowledge in the field of veterinary and/or comparative oncology
    • Relevance of the proposal to existing scientific knowledge
    • Feasibility of the study, including: likelihood of success in achieving study objectives and obtaining publishable results; appropriateness of study design; realistic time frame for completion (e.g., institutional case load for clinical proposals)
    • Adequacy of facility space/infrastructure/equipment, prior research productivity
    • Adequacy of Animal Involvement Justification (Protection/Safety)

PROPOSAL GUIDELINES

A complete application in the form of a single pdf file must be submitted by email attachment at a specified date (timetable for 2018 will be determined and announced in fall of 2017).

Document format:

  • Proposals should be written on 8.5 × 11 inch paper with a minimum of 3⁄4 inch margins
  • Single-spaced using no smaller than an 11-point Times New Roman font
  • Page limits for each section must be strictly observed.
  • The order of the written proposal should follow the outline described below, including use of the outline numbering and headings.
  • If any of the sections are not applicable, indicate this with “N/A”.
  • Figures, tables and graphics must be included in the “Study Proposal” page limit. Addenda and extra information beyond the page limit will not be reviewed.
  • Failure to adhere to these guidelines will result in disqualification

Proposal structure and limits:

  • Cover page (1-page max): Title of proposed study; name, affiliation (academic/practice entity), email, and postal mailing address of the resident, resident advisor, all investigators; name of the agency to which the grant would be payable; amount requested; signature of the resident, Resident Advisor and appropriate grant administrator(s).
  • Study Proposal (5-page limit including the headings outlined below):
    1. Summary (1-page max): To include:
      • Title
      • Hypothesis/Objective(s)
      • Relevance statement (description of problem and need for the research being proposed)
    2. Research Strategy (3 pages max): To include:
      • Background and significance.
      • Preliminary data (if applicable).
      • Experimental design and methods.
      • Analysis (statistical methods, sample size justification if applicable).
      • Expected results.
      • Resources and timeline for completion.
    3. Budget and Justification (1-page max): Allowable items:
      • Personnel –salary for resident and advisor are not allowed. Technician, data management individuals may be allowable
      • Equipment – purchase of major equipment is not allowable.
      • Supplies
      • Patient care costs (if applicable)
      • Other expenses
      • Indirect costs: Because VCS is a not-for-profit organization, indirect/overhead/F&A are never provided..
    4. References (1-page maximum): Pertinent related literature references
    5. Biographical sketch (2 pages each maximum): NIH style biosketch of Resident, Resident-advisor and any co-investigators
    6. Client consent form (2-page maximum) if applicable: Copy of proposed client consent form
    7. Resident Advisor statement (1-page): The residency advisor must sign off on the project in the form of letter stating:
      • A willingness to ensure completion of the project in the 1-year time-frame
      • A commitment to have the completed project presented (by the resident) in the form or either an oral or poster presentation at a VCS meeting within 3 years of project funding.
      • A commitment to provide annual progress reports until results are presented at the VCS meeting.

    Animal Involvement:  The study should be approved by an Institutional Animal Care and Use Committee (IACUC) and documentation of this approval (or pending approval) must be provided in the event the funding is awarded.  If there is no IACUC approval process available at the institution/entity, the VCS will provide a mechanism for similar approval.

    2017-18 TIMELINE:

    • Application announcement: Fall 2017 following the Annual Conference
    • Expected deadline for receipt of applications: January 17, 2018
    • Expected award announcements: March 1, 2018
    • Expected funding to be distributed: June 1, 2018.